HCRTR1 and prostate cancer: Further investigation demonstrated that thestimulation of OX1R can antagonize testosterone-induced androgen receptor nuclear translocation, suggesting that orexin-A might play a role in the regulation of androgen/androgen receptor signaling in prostate cancer (20).